GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Otsuka Holdings Co Ltd (OTCPK:OTSKY) » Definitions » Cyclically Adjusted PS Ratio

OTSKY (Otsuka Holdings Co) Cyclically Adjusted PS Ratio : 2.39 (As of May. 31, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Otsuka Holdings Co Cyclically Adjusted PS Ratio?

As of today (2025-05-31), Otsuka Holdings Co's current share price is $25.35. Otsuka Holdings Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $10.61. Otsuka Holdings Co's Cyclically Adjusted PS Ratio for today is 2.39.

The historical rank and industry rank for Otsuka Holdings Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

OTSKY' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.35   Med: 1.82   Max: 3.11
Current: 2.18

During the past years, Otsuka Holdings Co's highest Cyclically Adjusted PS Ratio was 3.11. The lowest was 1.35. And the median was 1.82.

OTSKY's Cyclically Adjusted PS Ratio is ranked worse than
50.95% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.115 vs OTSKY: 2.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Otsuka Holdings Co's adjusted revenue per share data for the three months ended in Mar. 2025 was $3.647. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $10.61 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Otsuka Holdings Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Otsuka Holdings Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Otsuka Holdings Co Cyclically Adjusted PS Ratio Chart

Otsuka Holdings Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.78 1.63 1.56 1.82 2.75

Otsuka Holdings Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.13 2.26 2.65 2.75 2.45

Competitive Comparison of Otsuka Holdings Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Otsuka Holdings Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Otsuka Holdings Co's Cyclically Adjusted PS Ratio falls into.


;
;

Otsuka Holdings Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Otsuka Holdings Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=25.35/10.61
=2.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otsuka Holdings Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Otsuka Holdings Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.647/111.1000*111.1000
=3.647

Current CPI (Mar. 2025) = 111.1000.

Otsuka Holdings Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 2.690 98.400 3.037
201509 2.775 98.500 3.130
201512 2.429 98.100 2.751
201603 2.290 97.900 2.599
201606 2.692 98.100 3.049
201609 2.742 98.000 3.109
201612 2.430 98.400 2.744
201703 2.290 98.100 2.593
201706 2.622 98.500 2.957
201709 2.696 98.800 3.032
201712 2.622 99.400 2.931
201803 2.564 99.200 2.872
201806 2.713 99.200 3.038
201809 2.714 99.900 3.018
201812 2.828 99.700 3.151
201903 2.606 99.700 2.904
201906 3.048 99.800 3.393
201909 3.066 100.100 3.403
201912 3.106 100.500 3.434
202003 2.908 100.300 3.221
202006 3.050 99.900 3.392
202009 3.244 99.900 3.608
202012 3.161 99.300 3.537
202103 2.857 99.900 3.177
202106 3.198 99.500 3.571
202109 3.252 100.100 3.609
202112 3.165 100.100 3.513
202203 2.957 101.100 3.249
202206 2.986 101.800 3.259
202209 2.906 103.100 3.131
202212 3.223 104.100 3.440
202303 3.091 104.400 3.289
202306 3.254 105.200 3.436
202309 3.312 106.200 3.465
202312 3.452 106.800 3.591
202403 3.195 107.200 3.311
202406 3.439 108.200 3.531
202409 4.005 108.900 4.086
202412 3.601 110.700 3.614
202503 3.647 111.100 3.647

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Otsuka Holdings Co  (OTCPK:OTSKY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Otsuka Holdings Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Otsuka Holdings Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Otsuka Holdings Co Business Description

Traded in Other Exchanges
Address
2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, JPN, 101-0048
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.